Societal Issues

Homeless AIDS Patients Should Have Access to Protease Drugs

Published in AIDS Weekly, July 14th, 1997

The HIV infected urban poor should be given access to protease inhibitors, said a group of University of California at San Francisco researchers specializing in studies of the homeless and marginally housed.

Many homeless can adhere to the complex treatment regimens required and not to make them available would be discriminatory, according to the researchers. To give the new therapies a chance, however, basic needs should come first in the treatment of homeless patients, the UCSF team advises.

Before prescribing complicated and rigorous therapy with protease inhibitors and other antiretroviral drugs, the initial goal in treating homeless persons...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-07-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry